Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

DuPont Tate & Lyle Bio Products Announces New Application for Zemea® Propanediol
  • USA - English


News provided by

DuPont Tate & Lyle Bio Products Company LLC

Mar 20, 2014, 08:00 ET

Share this article

Share toX

Share this article

Share toX


WILMINGTON, Del. (PRWEB) March 20, 2014 -- DuPont Tate & Lyle Bio Products Company LLC applauds Cheryl Lee MD, Sensitive Skin Care for launching the TrueLipids® line of therapeutic, hypoallergenic and non-toxic skin care products made with Zemea® propanediol.

One of the critical ingredients in our formulations is Zemea® propanediol,” said Dr. Cheryl Lee Eberting, board certified dermatologist and inventor of TrueLipids®. “

Post this

The patent-pending line of TrueLipids® products are all designed to work with the skin to augment its own repair mechanisms in fixing a disrupted skin barrier, to discourage the colonization/growth of S. aureus, and to optimize skin lipid production while being cosmetically elegant, very effective, truly hypoallergenic and non-toxic. Products in the TrueLipids® line that are made with Zemea® include TrueLipids® TrueTherapy™ Deep Moisturizing Ceramide+ Cream For Body, TrueLipids® Hydrate, Correct & Perfect Lotion For Face and Body and TrueLipids® Eczema Experts™ 1 percent Hydrocortisone Anti-Itch Barrier Cream.

“One of the critical ingredients in our formulations is Zemea® propanediol,” said Dr. Cheryl Lee Eberting, board certified dermatologist and inventor of TrueLipids®. “Instead of using a petrol-derived propylene glycol, this plant-based natural alternative was used. Allergy to petrol-based propylene glycol is very common and we felt it was very important to avoid it in our formulations. Because the plant-based molecule is slightly different, it is likely to be less-allergenic and safer. To our knowledge, no allergic reaction to Zemea® in commercial personal care products has ever been documented. We are happy to have a non-petrol alternative that has a good sensitization track record.”

Zemea® propanediol is a natural, 100 percent biobased ingredient made through fermentation of corn glucose and developed for use in the cosmetics and personal care market. It is a high-performance, environmentally sustainable alternative to petroleum-based glycols and glycerin in which the product’s lack of skin irritation, improved moisturization, antimicrobial efficacy and excellent aesthetic properties are benefits. Zemea® is approved as a natural ingredient by Ecocert and the Natural Products Association, is certified 100 percent biobased by the U.S. Department of Agriculture and has both Kosher and Halal certifications.

“We are excited to see leading dermatologists, such as Dr. Cheryl Lee Eberting, recognize the benefits that Zemea® provides to consumers with sensitive skin conditions,” commented Rose Durham, marketing manager for DuPont Tate & Lyle Bio Products. “TrueLipids® therapeutic products will be a cost-effective, over-the-counter alternative to prescription products used to treat atopic dermatitis, all forms of eczema, dry skin, itchy skin and for anti-aging.”

The TrueLipids® complete skincare line will be launched on March 20, 2014, at the Annual Meeting of the American Academy of Dermatology in Denver, Colo., and will be available for purchase through physician’s offices and online soon at CherylLeeMD.com.

DuPont Tate & Lyle Bio Products is a joint venture between DuPont, a global science company, and Tate & Lyle, a global provider of ingredients and solutions to the food, beverage and other industries. DuPont Tate & Lyle Bio Products provides natural and renewably sourced ingredients that enhance product performance. For more information on the company’s products, visit http://www.duponttateandlyle.com.

Cheryl Lee MD, Sensitive Skin Care was founded by Cheryl Lee D. Eberting, M.D., a board certified dermatologist and past clinical research fellow of the Dermatology Branch, National Cancer Institute, and National Institute of Health (NIH). She is the inventor of TrueLipids®, a patent-pending line of products containing the break-through TrueLipids® bled, lipid release technology and pH Protect™. This technology works with the skin to augment its own barrier repair mechanisms in restoring a disrupted skin barrier. Cheryl Lee MD products are the only skincare products on the market to be truly this therapeutic, hypoallergenic and non-toxic.

Zemea® and the circle logo are registered trademarks of DuPont Tate & Lyle Bio Products Company LLC.

TrueLipids® is a registered trademark of Cheryl Lee MD, Sensitive Skin Care.

Rose Durham, DuPont Tate & Lyle Bio Products Company LLC, http://www.duponttateandlyle.com, 3029992390, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.